Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 11, 2023
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
Mitchell Kapoor Maintained (carm) at Strong Buy with Increased Target to $11 on, Aug 11th, 2023
Mitchell Kapoor of HC Wainwright & Co., Maintained "Carisma Therapeutics, Inc." (CARM) at Strong Buy with Increased Target from $10 to $11 on, Aug 11th, 2023.
Mitchell has made no other calls on CARM in the last 4 months.
There are 2 other peers that have a rating on CARM. Out of the 2 peers that are also analyzing CARM, 0 agree with Mitchell's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Mitchell
- Liisa Bayko of "Evercore ISI Group" Initiated at Buy and Held Target at $12 on, Thursday, July 6th, 2023
- Jack Allen of "Baird" Reiterated at Buy and Held Target at $10 on, Wednesday, June 28th, 2023
